These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6342957)

  • 61. [Advantage of the diuretic "thiazide-spironolactone" associati in the treatment of arterial hypertension].
    Lagrue G; Ménard J; Schlotterer P; Safar M
    Presse Med (1893); 1969 Dec; 77(56):2157-8. PubMed ID: 5374259
    [No Abstract]   [Full Text] [Related]  

  • 62. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Metabolic and hypotensive effects of a new rauwolfia-thiazide combination.
    Hutchison JC
    Geriatrics; 1969 Jul; 24(7):68-74. PubMed ID: 5789861
    [No Abstract]   [Full Text] [Related]  

  • 64. Incidence of cardiac arrhythmias associated with mild hypokalemia induced by low-dose diuretic therapy for hypertension.
    Peters RW; Hamilton J; Hamilton BP
    South Med J; 1989 Aug; 82(8):966-9, 976. PubMed ID: 2669155
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The progress of patients in the European Working Party on Hypertension in the Elderly trial.
    Amery A; Beard K; Birkenhäger W; Bogaert M; Brixko P; Bulpitt C; Clement D; de Leeuw P; De Plaen JF; Deruyettere M
    Acta Med Scand Suppl; 1983; 676():119-40. PubMed ID: 6362343
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Propranolol, triamteren and hydrochlorothiazide in fixed combinations in the treatment of hypertension (author's transl)].
    Herrmann JM; Hiemstra S; Hoenig B
    Dtsch Med Wochenschr; 1981 Sep; 106(36):1138-43. PubMed ID: 7261940
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Potassium-sparing effect of triamterene in a 3-component combination preparation for the therapy of hypertension].
    Nagler J; Dittrich H
    Wien Klin Wochenschr; 1986 Jan; 98(2):49-53. PubMed ID: 3962310
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [A combination of methyldopa, hydrochlorothiazide and amiloride in the treatment of essential hypertension].
    Bolzano K; Krempler F; Sandhofer F
    Acta Med Austriaca; 1984; 11(2):49-53. PubMed ID: 6377793
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Combination of beta-receptor blocking agents and saluretica in outpatient treatment of hypertension. Results of a comparative study (author's transl)].
    Hoffmann J; Schrey A; Grund R; Forst T
    MMW Munch Med Wochenschr; 1981 Mar; 123(12):483-8. PubMed ID: 6783861
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A double-blind study of tienilic acid with two year follow-up of patients with mild to moderate essential hypertension.
    Okun R; Beg MA
    Postgrad Med J; 1979; 55 Suppl 3():103-9. PubMed ID: 388395
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biochemical and haematological changes induced by tienilic acid combined with propranolol in essential hypertension.
    Pearson RM; Bulpitt CJ; Havard CW
    Lancet; 1979 Mar; 1(8118):697-9. PubMed ID: 85937
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Serum potassium concentrations after initiation of captopril therapy.
    Schuna AA; Schmidt GR; Pitterle ME
    Clin Pharm; 1986 Nov; 5(11):920-3. PubMed ID: 3536269
    [No Abstract]   [Full Text] [Related]  

  • 73. Use of a diuretic (Dyazide) in the treatment of Menière's disease. A double-blind cross-over placebo-controlled study.
    van Deelen GW; Huizing EH
    ORL J Otorhinolaryngol Relat Spec; 1986; 48(5):287-92. PubMed ID: 3537899
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tolerance and side-effects of the association hydrochlorothiazide-amiloride in long-term treatment of arterial hypertension.
    Hubert C; Demanet JC; Degaute JP; Fichefet JP; Paduart P
    Acta Clin Belg; 1974; 29(5):294-8. PubMed ID: 4440394
    [No Abstract]   [Full Text] [Related]  

  • 75. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
    Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
    Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Therapy of heart failure with combined furosemide retard/triamterene].
    Burkhardt H; Graul EH; Pfab R; Schuster O; Loew D
    Fortschr Med; 1984 Jul; 102(27-28):735-9. PubMed ID: 6479817
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Long-term medical management of aldosterone-producing adenoma.
    Bornemann M
    South Med J; 1990 Apr; 83(4):461-2. PubMed ID: 2108504
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial.
    Staessen J
    Am J Med; 1991 Mar; 90(3A):50S-54S. PubMed ID: 2006662
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of mild-to-moderate hypertension: comparison between a calcium-channel blocker and a potassium-sparing diuretic.
    Boulet AP; Chockalingam A; Fodor JG; Laplante L; Houde M; Lenis J; Logan AG; Robitaille MN; Ryan D; Spénard J
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S45-50. PubMed ID: 1725543
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
    Zawada ET
    Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.